Figure 2:
Rates of response, remission, and mucosal healing in the induction phase of the GEMINI 1 trial.21 **Statistically significant difference for vedolizumab (Vedo) vs placebo (p≤0.001); p value not reported for open-label Vedo vs placebo.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.